These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 25996892)
1. Darbepoetin administration to neonates undergoing cooling for encephalopathy: a safety and pharmacokinetic trial. Baserga MC; Beachy JC; Roberts JK; Ward RM; DiGeronimo RJ; Walsh WF; Ohls RK; Anderson J; Mayock DE; Juul SE; Christensen RD; Loertscher MC; Stockmann C; Sherwin CM; Spigarelli MG; Yoder BA Pediatr Res; 2015 Sep; 78(3):315-22. PubMed ID: 25996892 [TBL] [Abstract][Full Text] [Related]
2. Population Pharmacokinetics of Darbepoetin Alfa in Conjunction with Hypothermia for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy. Roberts JK; Stockmann C; Ward RM; Beachy J; Baserga MC; Spigarelli MG; Sherwin CM Clin Pharmacokinet; 2015 Dec; 54(12):1237-44. PubMed ID: 25989868 [TBL] [Abstract][Full Text] [Related]
3. Population Pharmacokinetics of Darbepoetin in Infants Following Single Intravenous and Subcutaneous Dosing. An G; Ohls RK; Christensen RD; Widness JA; Mock DM; Veng-Pedersen P J Pharm Sci; 2017 Jun; 106(6):1644-1649. PubMed ID: 28189627 [TBL] [Abstract][Full Text] [Related]
5. Darbepoetin as a neuroprotective agent in mild neonatal encephalopathy: a randomized, placebo-controlled, feasibility trial. DuPont TL; Baserga M; Lowe J; Zamora T; Beauman S; Ohls RK J Perinatol; 2021 Jun; 41(6):1339-1346. PubMed ID: 33986477 [TBL] [Abstract][Full Text] [Related]
6. High-dose erythropoietin population pharmacokinetics in neonates with hypoxic-ischemic encephalopathy receiving hypothermia. Frymoyer A; Juul SE; Massaro AN; Bammler TK; Wu YW Pediatr Res; 2017 Jun; 81(6):865-872. PubMed ID: 28099423 [TBL] [Abstract][Full Text] [Related]
7. Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics. Wu YW; Bauer LA; Ballard RA; Ferriero DM; Glidden DV; Mayock DE; Chang T; Durand DJ; Song D; Bonifacio SL; Gonzalez FF; Glass HC; Juul SE Pediatrics; 2012 Oct; 130(4):683-91. PubMed ID: 23008465 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease. Smith WB; Dowell JA; Pratt RD Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688 [TBL] [Abstract][Full Text] [Related]
9. Darbepoetin alfa: a novel erythropoiesis-stimulating protein. Joy MS Ann Pharmacother; 2002; 36(7-8):1183-92. PubMed ID: 12086553 [TBL] [Abstract][Full Text] [Related]
10. Darbepoetin Administration in Term and Preterm Neonates. Patel S; Ohls RK Clin Perinatol; 2015 Sep; 42(3):557-66. PubMed ID: 26250917 [TBL] [Abstract][Full Text] [Related]
11. A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety. Juul SE; McPherson RJ; Bauer LA; Ledbetter KJ; Gleason CA; Mayock DE Pediatrics; 2008 Aug; 122(2):383-91. PubMed ID: 18676557 [TBL] [Abstract][Full Text] [Related]